| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
R.SVDLTATPR.A Y 2.35 2.93 480.2661 45.48 - 50.49 2 1.9E5 48.36 371 379 Y
R.FNPVSGEVSGAYPK.D Y 2.26 5.88 726.3695 70.01 - 73.47 2 1.7E5 71.66 216 229 Y
K.INAISTDDEGK.S Y 2.69 5.53 581.7886 35.54 - 40.81 2 1.2E5 38.22 257 267 Y
K.GNTFFFK.G Y 2.94 5.63 430.7230 86.67 - 90.55 2 1E5 88.49 63 69 N
R.MAPVPQPVTNALLGCQD Y 2.56 0.97 877.4410 120.65 - 123.77 2 8.7E4 121.98 424 440 N
K.GSHLWK.G Y 2.00 0.51 364.2020 34.95 - 38.93 2 8.5E4 36.95 70 75 N
K.SGLHSFPITR.S Y 1.87 4.76 372.2088 58.28 - 63.52 3 8E4 61.65 284 293 N
K.GHDVHIYDITTR.T Y 1.79 0.49 476.2454 53.05 - 60.78 3 7.6E4 57.57 171 182 N
K.TWSHLPVC(+57.02)TSALR.W Y 2.43 9.17 509.9343 81.78 - 85.07 3 6.1E4 83.45 188 200 N Carbamidomethylation
K.EIQEDFPGVPSHLDAAVECPK.G Y 1.92 1.48 761.0402 103.25 - 106.20 3 5.7E4 104.52 138 158 N
K.GECMANSVLFFK.G Y 2.24 0.71 673.3236 117.41 - 120.15 2 5.1E4 118.59 159 170 N
K.GEC(+57.02)MANSVLFFK.G Y 1.73 2.69 701.8335 111.92 - 114.60 2 3.6E4 113.45 159 170 N Carbamidomethylation
K.MYMIK.D Y 2.30 4.51 343.1774 52.80 - 57.38 2 3.4E4 55.48 312 316 N
K.TWSHLPVCTSALR.W Y 0.83 0.01 490.9277 85.81 - 91.60 3 3.4E4 88.28 188 200 N
K.SGLHSFPITR.S Y 0.53 2.68 557.8077 59.52 - 63.11 2 2.6E4 61.56 284 293 N
K.EIQEDFPGVPSHLDAAVEC(+57.02)PK.G Y 1.54 1.41 780.0438 97.48 - 100.07 3 2.6E4 98.84 138 158 N Carbamidomethylation
K.DDHVYIYK.T Y 0.92 1.31 526.7623 47.34 - 50.49 2 2.6E4 49.13 317 324 N
K.EVTQGVDAVFAYDDK.M Y 1.21 2.70 828.9005 92.34 - 97.79 2 2.5E4 94.42 297 311 N
K.DDHVYIYK.T Y 2.08 3.71 351.5093 45.75 - 50.81 3 2.4E4 48.65 317 324 N
K.TAAHYMLIEGYPK.T Y 1.38 1.00 747.3825 79.09 - 82.68 2 2.3E4 80.70 325 337 N
K.T(+43.01)WSHLPVCTSALR.W Y 1.10 0.70 505.2635 82.53 - 86.49 3 2.2E4 84.78 188 200 N Carbamylation
R.FNPVSGEVSGAYPK.D Y 0.82 1.98 726.3848 68.39 - 72.36 2 1.7E4 70.44 216 229 N
K.SYLFSGSMYVR.L Y 1.17 1.69 655.3130 104.92 - 109.37 2 1.6E4 106.30 268 278 N
K.G(+43.01)ECMANSVLFFK.G Y 1.71 0.07 694.8266 113.69 - 116.34 2 1.6E4 115.30 159 170 N Carbamylation
K.GNTFFFK.G Y 1.79 2.41 860.4380 86.60 - 90.16 1 1.6E4 88.48 63 69 N
K.GSHLWK.G Y 1.06 1.12 727.3936 33.62 - 39.00 1 1.4E4 36.57 70 75 N
K.EIQEDFPGVPSHLDAAVECPK(+43.01).G Y 0.64 0.29 775.3755 98.34 - 101.11 3 1.4E4 99.73 138 158 N Carbamylation
K.SYLFSGSMYVR.L Y 0.69 0.21 655.3284 102.14 - 105.63 2 1.3E4 103.59 268 278 N
R.MAPVPQPVTNALLGC(+57.02)QD Y 0.71 0.11 905.9448 113.37 - 116.97 2 1.2E4 115.75 424 440 N Carbamidomethylation
K.G(+43.01)SHLWK.G Y 0.53 0.44 385.7018 46.24 - 51.36 2 9.7E3 48.67 70 75 N Carbamylation
R.MAPVPQPVTNALLGCQD Y 1.02 0.48 585.2974 120.90 - 123.26 3 9.5E3 121.99 424 440 N
K.TWSHLPVCTSALR.W Y 0.22 0.89 735.8878 85.74 - 89.42 2 7.2E3 87.09 188 200 N
K.MYMIKDDHVYIYK.T Y 1.38 3.57 430.4659 77.58 - 80.39 4 7.2E3 78.98 312 324 N
K.MYMIKDDHVYIYK.T Y 0.41 0.65 573.6207 77.51 - 80.06 3 6.9E3 78.79 312 324 N
K.INAISTDDEGKSY.L Y 0.30 1.45 706.8377 48.27 - 52.81 2 6.4E3 51.18 257 269 N
R.CAGIEFDAITPDEK.G Y 0.30 0.04 754.8620 92.09 - 96.42 2 6.3E3 94.28 49 62 N
R.H(+43.01)YFMR.C Y 1.31 2.86 398.6868 53.15 - 58.25 2 5.5E3 55.35 233 237 N Carbamylation
K.EIQEDFPGVPSHLDAAVECPK.G Y 1.38 2.03 1141.0480 103.10 - 105.84 2 4.7E3 104.59 138 158 N
K.EVTQGVDAVFAYDDK.M Y 0.08 0.46 828.9125 91.77 - 97.53 2 3.7E3 92.74 297 311 N
R.MAPVPQPVTNALLGC(+57.02)QD Y 0.11 3.40 604.3016 115.34 - 116.31 3 2.9E3 115.98 424 440 N Carbamidomethylation
R.MAPVPQPVTNALLGC(+57.02)QD Y 0.11 0.48 905.9180 115.19 - 120.02 2 2.6E3 116.48 424 440 N Carbamidomethylation
K.GEC(+57.02)MANSVLFFK.G Y 0.42 2.12 468.2277 112.30 - 116.17 3 2.1E3 113.73 159 170 N Carbamidomethylation
K.GECMANSVLFFK.G Y 0.61 0.04 449.2164 117.68 - 119.44 3 1.4E3 118.61 159 170 N
total 43 peptides